Alterity Therapeutics Limited Share Price Nasdaq
Stocks
ATHE
US02155X2053
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.890 USD | +1.45% |
|
-0.81% | +58.77% |
| Market Cap | 85.31M 74.7M 68.96M 64.39M 121M 8.07B 124M 830M 320M 3.98B 320M 313M 13.81B | P/E 2026 * |
-0.23x | P/E 2027 * | -0.23x |
|---|---|---|---|---|---|
| Enterprise Value | 40.12M 35.13M 32.43M 30.28M 57.01M 3.79B 58.31M 390M 151M 1.87B 151M 147M 6.5B | EV / Sales 2026 * |
11.7x | EV / Sales 2027 * | 27.8x |
| Free-Float |
91.47% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Alterity Therapeutics Limited
| 1 day | +1.45% | ||
| 1 week | -0.81% | ||
| Current month | +18.69% | ||
| 1 month | +18.69% | ||
| 3 months | +54.75% | ||
| 6 months | +61.92% | ||
| Current year | +58.77% |
| 1 week | 4.76 |  | 5.3 |
| 1 month | 3.88 | | 5.3 |
| Current year | 3.02 | | 5.3 |
| 1 year | 2.66 | | 7 |
| 3 years | 1 | | 7 |
| 5 years | 1 | | 27.5 |
| 10 years | 1 | | 66.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 65 | 06/01/2021 |
Abby Niven
DFI | Director of Finance/CFO | - | 29/09/2024 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Marks
BRD | Director/Board Member | 70 | 28/07/2005 |
Lawrence Gozlan
BRD | Director/Board Member | 47 | 07/08/2011 |
David Stamler
BRD | Director/Board Member | 65 | 20/11/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.45% | -0.81% | - | - | 85.31M | |
| +1.11% | +5.98% | -3.36% | +2.36% | 46.62B | |
| +5.79% | +16.17% | +421.86% | +634.63% | 40.95B | |
| +1.12% | +15.18% | +22.74% | -12.71% | 32.26B | |
| +3.61% | +6.69% | +20.23% | +62.38% | 32.24B | |
| +8.02% | +6.35% | +17.67% | +34.73% | 25.53B | |
| +1.13% | +15.66% | - | - | 16.38B | |
| +1.45% | +17.35% | +72.11% | +127.60% | 15.27B | |
| +0.21% | +4.72% | +13.04% | +17.47% | 13.61B | |
| -0.60% | +6.32% | +102.74% | +96.28% | 13.34B | |
| Average | +2.33% | +11.58% | +83.38% | +120.34% | 26.24B | |
| Weighted average by Cap. | +2.89% | +11.59% | +98.28% | +145.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.42M 3M 2.77M 2.59M 4.87M 324M 4.98M 33.31M 12.86M 160M 12.86M 12.58M 555M | 1.6M 1.4M 1.29M 1.21M 2.27M 151M 2.33M 15.57M 6.01M 74.64M 6.01M 5.88M 259M |
| Net income | -14.62M -12.8M -11.82M -11.04M -20.78M -1.38B -21.25M -142M -54.91M -682M -54.92M -53.71M -2.37B | -22.29M -19.52M -18.02M -16.82M -31.67M -2.11B -32.39M -217M -83.7M -1.04B -83.71M -81.87M -3.61B |
| Net Debt | -45.19M -39.57M -36.53M -34.11M -64.21M -4.27B -65.67M -440M -170M -2.11B -170M -166M -7.32B | -40.88M -35.8M -33.05M -30.86M -58.09M -3.87B -59.41M -398M -154M -1.91B -154M -150M -6.62B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/06/26 | US$4.890 | +1.45% | 21,895 |
| 26/06/26 | US$4.820 | -1.63% | 23,412 |
| 25/06/26 | US$4.900 | -3.26% | 41,756 |
| 24/06/26 | US$5.065 | +2.12% | 34,452 |
| 23/06/26 | US$4.960 | +0.61% | 13,801 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATH Stock
- ATHE Stock
Select your edition
All financial news and data tailored to specific country editions
